CG
Caprock Group’s Adaptive Biotechnologies ADPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $81.3K | Buy |
10,944
+529
| +5% | +$3.93K | ﹤0.01% | 1043 |
|
|
2024
Q4 | $62.4K | Sell |
10,415
-2,500
| -19% | -$15K | ﹤0.01% | 974 |
|
|
2024
Q3 | $66.1K | Buy |
12,915
+357
| +3% | +$1.83K | ﹤0.01% | 880 |
|
|
2024
Q2 | $45.5K | Sell |
12,558
-12,516
| -50% | -$45.3K | ﹤0.01% | 843 |
|
|
2024
Q1 | $80.5K | Sell |
25,074
-28
| -0.1% | -$90 | ﹤0.01% | 704 |
|
|
2023
Q4 | $123K | Sell |
25,102
-17
| -0.1% | -$83 | 0.01% | 669 |
|
|
2023
Q3 | $137K | Sell |
25,119
-300
| -1% | -$1.64K | 0.01% | 627 |
|
|
2023
Q2 | $171K | Hold |
25,419
| – | – | 0.01% | 623 |
|
|
2023
Q1 | $224K | Hold |
25,419
| – | – | 0.02% | 569 |
|
|
2022
Q4 | $194K | Sell |
25,419
-1,919
| -7% | -$14.7K | 0.02% | 511 |
|
|
2022
Q3 | $195K | Sell |
27,338
-414
| -1% | -$2.95K | 0.02% | 523 |
|
|
2022
Q2 | $225K | Sell |
27,752
-4,586
| -14% | -$37.2K | 0.02% | 467 |
|
|
2022
Q1 | $449K | Sell |
32,338
-3,000
| -8% | -$41.7K | 0.04% | 318 |
|
|
2021
Q4 | $992K | Sell |
35,338
-10,700
| -23% | -$300K | 0.08% | 176 |
|
|
2021
Q3 | $1.57M | Hold |
46,038
| – | – | 0.14% | 103 |
|
|
2021
Q2 | $1.88M | Sell |
46,038
-3,000
| -6% | -$123K | 0.17% | 93 |
|
|
2021
Q1 | $1.97M | Buy |
49,038
+18,758
| +62% | +$755K | 0.22% | 76 |
|
|
2020
Q4 | $1.79M | Sell |
30,280
-10,430
| -26% | -$617K | 0.2% | 81 |
|
|
2020
Q3 | $1.98M | Sell |
40,710
-7,500
| -16% | -$365K | 0.27% | 66 |
|
|
2020
Q2 | $2.33M | Hold |
48,210
| – | – | 0.35% | 52 |
|
|
2020
Q1 | $1.34M | Buy |
48,210
+40,672
| +540% | +$1.13M | 0.25% | 77 |
|
|
2019
Q4 | $226K | Buy |
7,538
+38
| +0.5% | +$1.14K | 0.04% | 302 |
|
|
2019
Q3 | $232K | Buy |
+7,500
| New | +$232K | 0.05% | 287 |
|